AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33635604 — intervention group
Group type: EXPERIMENTAL
Intervention: Regression model
Number of subjects: 0
Study 32043980 — intervention group
Group type: EXPERIMENTAL
Intervention: Local excision
Number of subjects: 145
Study 32043980 — intervention group
Group type: COMPARATOR
Intervention: Total mesorectal excision
Number of subjects: 145
Study 33177349 — intervention group
Group type: EXPERIMENTAL
Intervention: Infliximab (IFX) combo therapy
Number of subjects: 122
Study 34018375 — intervention group
Group type: COMPARATOR
Intervention: Conventional MRI
Number of subjects: 158
Study 34018375 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI after vaginal filling with ultrasound gel
Number of subjects: 158
Study 34234262 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcapsular castration (SC)
Number of subjects: 12
Study 34234262 — intervention group
Group type: COMPARATOR
Intervention: Open castration (OC)
Number of subjects: 12
Study 32176792 — intervention group
Group type: EXPERIMENTAL
Intervention: Linezolid administered intravenously at a standard dose of 600 mg every 12 hours with CVVH
Number of subjects: 20
Study 32176792 — intervention group
Group type: EXPERIMENTAL
Intervention: Linezolid administered intravenously at a standard dose of 600 mg every 12 hours with EDH
Number of subjects: 20
Study 32176792 — intervention group
Group type: COMPARATOR
Intervention: Standard 600 mg intravenous administration every 12 hours
Number of subjects: 20
Study 36440217 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-body vibration (WBV)
Number of subjects: 10
Study 36440217 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance exercise (RE)
Number of subjects: 10
Study 36440217 — intervention group
Group type: COMPARATOR
Intervention: Whole-body vibration (WBV) and Resistance exercise (RE)
Number of subjects: 10
Study 33741044 — intervention group
Group type: EXPERIMENTAL
Intervention: VIPP-SD intervention (Video-feedback to promote Positive Parenting and Sensitive Discipline)
Number of subjects: 202
Study 33741044 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 202
Study 33741044 — intervention group
Group type: EXPERIMENTAL
Intervention: VIPP-SD intervention
Number of subjects: 202
Study 36413635 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryoballoon ablation (CB)
Number of subjects: 230
Study 36413635 — intervention group
Group type: COMPARATOR
Intervention: Radiofrequency ablation (RF)
Number of subjects: 230
Study 33443915 — intervention group
Group type: EXPERIMENTAL
Intervention: Twice‐daily application of a commercially available skin and body lotion to the arms and legs of participants
Number of subjects: 128
Study 33443915 — intervention group
Group type: COMPARATOR
Intervention: Control group (no moisturizer application)
Number of subjects: 128
Study 32841300 — intervention group
Group type: EXPERIMENTAL
Intervention: Plyometric exercise (PLYO)
Number of subjects: 40
Study 32841300 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional resistance training (RT)
Number of subjects: 40
Study 32841300 — intervention group
Group type: COMPARATOR
Intervention: Walking (WALK)
Number of subjects: 40
Study 35139725 — intervention group
Group type: COMPARATOR
Intervention: Reirradiation and hyperthermia (standard arm)
Number of subjects: 49
Study 35139725 — intervention group
Group type: EXPERIMENTAL
Intervention: Reirradiation and hyperthermia plus cisplatin (combined arm)
Number of subjects: 49
Study 34062589 — intervention group
Group type: EXPERIMENTAL
Intervention: Team-based treatment (blended collaborative care) in secondary prevention
Number of subjects: 0
Study 34062589 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive psychology and mindfulness training
Number of subjects: 0
Study 34314877 — intervention group
Group type: EXPERIMENTAL
Intervention: YouTube-delivered aerobic and muscle-strengthening PA videos
Number of subjects: 64
Study 34314877 — intervention group
Group type: COMPARATOR
Intervention: General health education videos (Control)
Number of subjects: 64
Study 33744043 — intervention group
Group type: EXPERIMENTAL
Intervention: BUZZY® vibratory stimulation tool (switched on before injection)
Number of subjects: 118
Study 35014215 — intervention group
Group type: EXPERIMENTAL
Intervention: Adapted physical activity (APA) intervention consisting of aerobic and resistance exercises, moderate intensity, delivered at two sessions per week for 9 months.
Number of subjects: 61
Study 35014215 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention details provided).
Number of subjects: 61
Study 35014215 — intervention group
Group type: EXPERIMENTAL
Intervention: Adapted physical activity (APA) intervention.
Number of subjects: 61
Study 33264556 — intervention group
Group type: EXPERIMENTAL
Intervention: Remdesivir
Number of subjects: 11330
Study 33264556 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine
Number of subjects: 11330
Study 33264556 — intervention group
Group type: EXPERIMENTAL
Intervention: Lopinavir
Number of subjects: 11330
Study 33264556 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon
Number of subjects: 11330
Study 33264556 — intervention group
Group type: COMPARATOR
Intervention: Control (no trial drug)
Number of subjects: 11330
Study 33988659 — intervention group
Group type: EXPERIMENTAL
Intervention: GSH-1 (1 mM)
Number of subjects: 60
Study 33988659 — intervention group
Group type: EXPERIMENTAL
Intervention: GSH-1 (1 mM) with ET-0
Number of subjects: 60
Study 33988659 — intervention group
Group type: COMPARATOR
Intervention: GSH-0 (0 mM) and GSH-1 (1 mM)
Number of subjects: 60
Study 35863686 — intervention group
Group type: EXPERIMENTAL
Intervention: AI-assisted colonoscopy (AI)
Number of subjects: 3059
Study 35863686 — intervention group
Group type: COMPARATOR
Intervention: Conventional colonoscopy (CC)
Number of subjects: 3059
Study 34582373 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin Degludec
Number of subjects: 50
Study 34582373 — intervention group
Group type: COMPARATOR
Intervention: Insulin Glargine
Number of subjects: 50
Study 34958366 — intervention group
Group type: EXPERIMENTAL
Intervention: Dronedarone
Number of subjects: 4588
Study 34958366 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4588
Study 33229279 — intervention group
Group type: EXPERIMENTAL
Intervention: Vignette conditions describing reproductively challenged women
Number of subjects: 554
Study 33229279 — intervention group
Group type: EXPERIMENTAL
Intervention: General access to ART
Number of subjects: 554
Study 33229279 — intervention group
Group type: EXPERIMENTAL
Intervention: Personal funds to assist women with access to ART
Number of subjects: 554
Study 33019981 — intervention group
Group type: EXPERIMENTAL
Intervention: Decrease in SMI (ΔSMI) during NACT
Number of subjects: 212
Study 33019981 — intervention group
Group type: COMPARATOR
Intervention: Stable/increase in SMI (ΔSMI) during NACT
Number of subjects: 212
Study 35141339 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-stage surgery (arthroscopic microfracture and modified Broström‐Gould procedure simultaneously)
Number of subjects: 103
Study 35141339 — intervention group
Group type: COMPARATOR
Intervention: Staged surgery (arthroscopic debridement of OLT and microfracture followed by rehabilitation, then modified Broström‐Gould procedure)
Number of subjects: 103
Study 35141339 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-stage surgery
Number of subjects: 103
Study 35141339 — intervention group
Group type: COMPARATOR
Intervention: Staged surgery
Number of subjects: 103
Study 616037435 — intervention group
Group type: EXPERIMENTAL
Intervention: Korean traditional music (KTM) played during surgery on the first eye
Number of subjects: 52
Study 616037435 — intervention group
Group type: COMPARATOR
Intervention: No music (control group) during surgery on the second eye
Number of subjects: 52
Study 34609939 — intervention group
Group type: EXPERIMENTAL
Intervention: Vorapaxar
Number of subjects: 102
Study 34609939 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 102
Study 34343292 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 µg/day of D3 for 8 weeks
Number of subjects: 18
Study 34343292 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 µg/day of 25(OH)D3 for 8 weeks
Number of subjects: 18
Study 34343292 — intervention group
Group type: EXPERIMENTAL
Intervention: D3 or 25(OH)D3 supplementation
Number of subjects: 18
Study 33228174 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise for Health intervention
Number of subjects: 0
Study 33228174 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study 35331677 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium sulphate (4 g of magnesium sulphate heptahydrate, 8 mmol magnesium ions)
Number of subjects: 109
Study 35331677 — intervention group
Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 109
Study 33714901 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy Recovery intervention (8-session group-based intervention targeting smoking, diet, and physical inactivity)
Number of subjects: 151
Study 33714901 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy Recovery intervention
Number of subjects: 151
Study 33714901 — intervention group
Group type: COMPARATOR
Intervention: Control condition (no intervention)
Number of subjects: 151
Study 32568845 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane anesthesia
Number of subjects: 210
Study 32568845 — intervention group
Group type: COMPARATOR
Intervention: Propofol anesthesia
Number of subjects: 210
Study 32568845 — intervention group
Group type: EXPERIMENTAL
Intervention: Natural killer cell activity
Number of subjects: 210
Study 35248289 — intervention group
Group type: EXPERIMENTAL
Intervention: Alexander Technique (performed in three 60-min sessions per week for 12 weeks)
Number of subjects: 80
Study 35248289 — intervention group
Group type: COMPARATOR
Intervention: Routine care for LBP patients (Control group)
Number of subjects: 80
Study 33963742 — intervention group
Group type: EXPERIMENTAL
Intervention: Stable liquid droplets (LS)
Number of subjects: 15
Study 33963742 — intervention group
Group type: COMPARATOR
Intervention: Acid-unstable emulsions (SU)
Number of subjects: 15
Study 32588926 — intervention group
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Number of subjects: 0
Study 32588926 — intervention group
Group type: COMPARATOR
Intervention: Brentuximab vedotin
Number of subjects: 0
Study 35227800 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular aortic repair (EVAR)
Number of subjects: 31471
Study 35233749 — intervention group
Group type: EXPERIMENTAL
Intervention: Implementation-intention intervention (IG)
Number of subjects: 69
Study 35233749 — intervention group
Group type: COMPARATOR
Intervention: Active control group (CG)
Number of subjects: 69
Study 32182434 — intervention group
Group type: EXPERIMENTAL
Intervention: ATP training (TOJ) over 14 days
Number of subjects: 82
Study 32182434 — intervention group
Group type: COMPARATOR
Intervention: Non-ATP training (intensity discrimination) over 14 days
Number of subjects: 82
Study 32182434 — intervention group
Group type: COMPARATOR
Intervention: No training
Number of subjects: 82
Study 36165996 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fat meal (FAT; 7% protein, 42% fat, 52% carbohydrate)
Number of subjects: 10
Study 36165996 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fat meal (FAT)
Number of subjects: 10
Study 36165996 — intervention group
Group type: COMPARATOR
Intervention: High-carbohydrate meal (CHO; 7% protein, 13% fat, 80% carbohydrate)
Number of subjects: 10
Study 36165996 — intervention group
Group type: COMPARATOR
Intervention: High-carbohydrate meal (CHO)
Number of subjects: 10
Study 34001020 — intervention group
Group type: EXPERIMENTAL
Intervention: Golf intervention (180 min training/week)
Number of subjects: 46
Study 34001020 — intervention group
Group type: EXPERIMENTAL
Intervention: Golf intervention
Number of subjects: 46
Study 34001020 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 46
Study 35619171 — intervention group
Group type: EXPERIMENTAL
Intervention: Range of motion exercises
Number of subjects: 90
Study 35619171 — intervention group
Group type: EXPERIMENTAL
Intervention: Massage
Number of subjects: 90
Study 35619171 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 90
Study 33364042 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose vitamin A plus E supplementation (AE group, N = 36)
Number of subjects: 98
Study 33364042 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose vitamin A plus E with zinc (AEZ group, N = 35)
Number of subjects: 98
Study 33364042 — intervention group
Group type: COMPARATOR
Intervention: No supplements (control group, N = 27)
Number of subjects: 98
Study 33544819 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg/kg/day valproic acid orally for 14 days
Number of subjects: 10
Study 33544819 — intervention group
Group type: COMPARATOR
Intervention: No valproic acid (control)
Number of subjects: 10
Study 32036587 — intervention group
Group type: EXPERIMENTAL
Intervention: BI 425809
Number of subjects: 200
Study 32036587 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study 34783270 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength exercises group
Number of subjects: 77
Study 34783270 — intervention group
Group type: EXPERIMENTAL
Intervention: Breathing exercises group
Number of subjects: 77
Study 34783270 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 77
Study 32859487 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral pectointercostal fascial block using ropivacaine injection 0.25%
Number of subjects: 40
Study 32859487 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention specified)
Number of subjects: 40
Study 35259633 — intervention group
Group type: EXPERIMENTAL
Intervention: Adrenaline
Number of subjects: 519
Study 35259633 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid
Number of subjects: 519
Study 35259633 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrogen peroxide
Number of subjects: 519
Study 35259633 — intervention group
Group type: EXPERIMENTAL
Intervention: Xylometazoline
Number of subjects: 519
Study 35259633 — intervention group
Group type: COMPARATOR
Intervention: Saline (Control)
Number of subjects: 519
Study 32270017 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated curriculum on conflicts of interest and communication of risk
Number of subjects: 32
Study 36156131 — intervention group
Group type: EXPERIMENTAL
Intervention: Levosimendan
Number of subjects: 849
Study 36156131 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 849
Study 36156131 — intervention group
Group type: EXPERIMENTAL
Intervention: LCOS
Number of subjects: 849
Study 34516497 — intervention group
Group type: EXPERIMENTAL
Intervention: Xianling Gubao capsule + glucosamine hydrochloride capsule simulation agent treatment
Number of subjects: 0
Study 34516497 — intervention group
Group type: COMPARATOR
Intervention: Glucosamine hydrochloride capsule + Xianling Gubao capsule simulation agent treatment
Number of subjects: 0
Study 36912173 — intervention group
Group type: EXPERIMENTAL
Intervention: Darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) 800/150/200/10 mg
Number of subjects: 1125
Study 36912173 — intervention group
Group type: COMPARATOR
Intervention: Control arm
Number of subjects: 1125
Study 34288958 — intervention group
Group type: EXPERIMENTAL
Intervention: Kenward and Roger Wald test power approximation
Number of subjects: 0
Study 34288958 — intervention group
Group type: EXPERIMENTAL
Intervention: Monte Carlo simulation
Number of subjects: 0
Study 34288958 — intervention group
Group type: EXPERIMENTAL
Intervention: Power calculation for an unbalanced group-randomized trial
Number of subjects: 0
Study 34772901 — intervention group
Group type: EXPERIMENTAL
Intervention: Montmorency cherry concentrate (MCC) supplementation
Number of subjects: 10
Study 32305653 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical debridement with adjuvant antimicrobial photodynamic therapy (aPDT)
Number of subjects: 36
Study 32305653 — intervention group
Group type: COMPARATOR
Intervention: Mechanical debridement alone
Number of subjects: 36
Study 32305653 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical debridement with and without aPDT
Number of subjects: 36
Study 35241006 — intervention group
Group type: EXPERIMENTAL
Intervention: Blister packaged IFA pills
Number of subjects: 950
Study 35241006 — intervention group
Group type: COMPARATOR
Intervention: Loose packaged IFA pills
Number of subjects: 950
Study 34019802 — intervention group
Group type: EXPERIMENTAL
Intervention: TAK-426 2 μg
Number of subjects: 271
Study 34019802 — intervention group
Group type: EXPERIMENTAL
Intervention: TAK-426 5 μg
Number of subjects: 271
Study 34019802 — intervention group
Group type: EXPERIMENTAL
Intervention: TAK-426 10 μg
Number of subjects: 271
Study 34019802 — intervention group
Group type: COMPARATOR
Intervention: TAK-426 10 μg vs 2 μg
Number of subjects: 271
Study 34019802 — intervention group
Group type: COMPARATOR
Intervention: TAK-426 10 μg vs 5 μg
Number of subjects: 271
Study 34019802 — intervention group
Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 271
Study 35384852 — intervention group
Group type: EXPERIMENTAL
Intervention: CuNET scale (texting-based condom negotiation)
Number of subjects: 242
Study 35384852 — intervention group
Group type: EXPERIMENTAL
Intervention: CuNET score increase
Number of subjects: 242
Study 33950027 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous tibial nerve stimulation (PTNS)
Number of subjects: 165
Study 33950027 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 165
Study 33950027 — intervention group
Group type: EXPERIMENTAL
Intervention: PTNS or sham
Number of subjects: 165
Study 32368027 — intervention group
Group type: EXPERIMENTAL
Intervention: UMEC 62.5 mcg
Number of subjects: 306
Study 32368027 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 306
Study 32368027 — intervention group
Group type: EXPERIMENTAL
Intervention: UMEC
Number of subjects: 306
Study 32368027 — intervention group
Group type: COMPARATOR
Intervention: UMEC and Placebo
Number of subjects: 306
Study 35811050 — intervention group
Group type: EXPERIMENTAL
Intervention: CBD-rich oil administered within the reconsolidation window
Number of subjects: 99
Study 35811050 — intervention group
Group type: COMPARATOR
Intervention: Placebo oil administered within the reconsolidation window
Number of subjects: 99
Study 35811050 — intervention group
Group type: EXPERIMENTAL
Intervention: CBD-rich oil administered outside of the reconsolidation window
Number of subjects: 99
Study 33934618 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxytocin infusion at 1.25 IU/hour
Number of subjects: 120
Study 33934618 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxytocin infusion at 2.5 IU/hour
Number of subjects: 120
Study 33934618 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxytocin infusion at 5.0 IU/hour
Number of subjects: 120
Study 33934618 — intervention group
Group type: COMPARATOR
Intervention: Comparison of 1.25 IU/hour vs 5 IU/hour
Number of subjects: 120
Study 33934618 — intervention group
Group type: COMPARATOR
Intervention: Comparison of haemoglobin levels
Number of subjects: 120
Study 33934618 — intervention group
Group type: COMPARATOR
Intervention: Comparison of incidence of tachycardia
Number of subjects: 120
Study 33934618 — intervention group
Group type: COMPARATOR
Intervention: Comparison of incidence of hypotension
Number of subjects: 120
Study 33934618 — intervention group
Group type: COMPARATOR
Intervention: Comparison of incidence of nausea/vomiting
Number of subjects: 120
Study 32109318 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral tranexamic acid and hydroquinone 4% cream, sunscreen
Number of subjects: 50
Study 32109318 — intervention group
Group type: COMPARATOR
Intervention: Hydroquinone 4% cream, sunscreen, and placebo capsules
Number of subjects: 50
Study 91357366 — intervention group
Group type: EXPERIMENTAL
Intervention: Human immune serum globulin
Number of subjects: 0
Study 91357366 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 35469409 — intervention group
Group type: EXPERIMENTAL
Intervention: Everolimus plus reduced tacrolimus (EVR + rTAC)
Number of subjects: 211
Study 35469409 — intervention group
Group type: COMPARATOR
Intervention: Mycophenolate mofetil plus tacrolimus (MMF + TAC)
Number of subjects: 211
Study 34560922 — intervention group
Group type: COMPARATOR
Intervention: Olfactory ensheathing cell therapy
Number of subjects: 0
Study 36056874 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 40 mg orally once daily for two weeks
Number of subjects: 52
Study 36056874 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study 33272965 — intervention group
Group type: EXPERIMENTAL
Intervention: Ziltivekimab 2 mg
Number of subjects: 61
Study 33272965 — intervention group
Group type: EXPERIMENTAL
Intervention: Ziltivekimab 6 mg
Number of subjects: 61
Study 33272965 — intervention group
Group type: EXPERIMENTAL
Intervention: Ziltivekimab 20 mg
Number of subjects: 61
Study 33272965 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study 37081779 — intervention group
Group type: EXPERIMENTAL
Intervention: INSIGHT Responsive Parenting Intervention
Number of subjects: 279
Study 37081779 — intervention group
Group type: COMPARATOR
Intervention: Safety Control
Number of subjects: 279
Study 32107133 — intervention group
Group type: EXPERIMENTAL
Intervention: Operated foramen in CSR patients
Number of subjects: 42
Study 32107133 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonoperated foramen in CSR patients
Number of subjects: 42
Study 32107133 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy subjects)
Number of subjects: 42
Study 32115477 — intervention group
Group type: EXPERIMENTAL
Intervention: Nalmefene 10 mg
Number of subjects: 0
Study 32115477 — intervention group
Group type: EXPERIMENTAL
Intervention: Nalmefene 20 mg
Number of subjects: 0
Study 32115477 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 33309466 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotional Freedom Techniques (EFT)
Number of subjects: 76
Study 33309466 — intervention group
Group type: EXPERIMENTAL
Intervention: Breathing Therapy
Number of subjects: 76
Study 32282729 — intervention group
Group type: EXPERIMENTAL
Intervention: Erector spinae plane (ESP) block
Number of subjects: 60
Study 32282729 — intervention group
Group type: COMPARATOR
Intervention: Periarticular infiltration
Number of subjects: 60
Study 33942396 — intervention group
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Number of subjects: 1
Study 33942396 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose glucocorticoids, antibiotics, and monoclonal anti-TNFα antibody
Number of subjects: 1